US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 11.980
  • -0.490-3.93%
Trading Jan 8 15:45 ET
1.22BMarket Cap-2.20P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.33%
ARK Portfolio
ARK Portfolio
Intraday-0.41%